The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Oral EPI-7386 in patients with metastatic castration-resistant prostate cancer.
 
Russell Kent Pachynski
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics; Bristol-Myers Squibb; Dendreon; EMD Serono; Genomic Health; Jounce Therapeutics; Pfizer/EMD Serono; Sanofi
Speakers' Bureau - AstraZeneca; Dendreon; Genentech/Roche; Genomic Health; Merck; Sanofi
Research Funding - Bristol Myers Squibb Foundation (Inst); Exelixis (Inst); Janssen Oncology; Pharmacyclics (Inst)
Patents, Royalties, Other Intellectual Property - Entitled: METHOD OF CELL-FREE DNA ANALYSIS TO IDENTIFY HIGH-RISK METASTATIC PROSTATE CANCER
Travel, Accommodations, Expenses - Genentech/Roche
 
Nicholas Iannotti
No Relationships to Disclose
 
Andrew Leonard Laccetti
Consulting or Advisory Role - Bayer; Bayer; Guidepoint Global; Third Bridge
 
Bradley Curtis Carthon
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Eisai; Immunomedics
Research Funding - Alkermes (Inst); MedImmune (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Kim N. Chi
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen; Merck; POINT Biopharma; Roche
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Constellation Pharmaceuticals; Daiichi Sankyo; ESSA; Janssen; Merck; POINT Biopharma; Roche; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); ESSA (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
Expert Testimony - AstraZeneca; Novartis
 
Matthew Raymond Smith
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Janssen Oncology; Lilly; Novartis; Pfizer
Research Funding - Bayer (Inst); ESSA (Inst); Janssen Oncology (Inst); Lilly (Inst); ORIC Pharmaceuticals (Inst)
 
Nicholas J. Vogelzang
Employment - US Oncology Network
Stock and Other Ownership Interests - Caribou Biosciences
Consulting or Advisory Role - Astellas Oncology; AstraZeneca; Bayer; Caris Life Sciences; Clovis Oncology; Genentech/Roche; Janssen; Merck; Pfizer
Speakers' Bureau - AVEO; Bristol-Myers Squibb; Myovant Sciences; Sanofi; Seattle Genetics/Astellas
Research Funding - Merck; Suzhou Kintor Pharmaceuticals; US Oncology
Expert Testimony - Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Sanofi
 
Wilson Tu
No Relationships to Disclose
 
Edmond Michael Kwan
Honoraria - Astellas Pharma; Ipsen; Janssen; Research Review
Consulting or Advisory Role - Astellas Pharma; Ipsen; Janssen
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen; Pfizer; Roche
 
Alexander William Wyatt
Honoraria - Astellas Pharma; AstraZeneca; AstraZeneca Canada; Janssen; Merck
Consulting or Advisory Role - AstraZeneca
Research Funding - ESSA (Inst)
 
Karen Villaluna
Employment - ESSA
Stock and Other Ownership Interests - ESSA
 
Brett Younginger
Employment - ESSA
Stock and Other Ownership Interests - ESSA
 
Alessandra Cesano
Employment - ESSA
Stock and Other Ownership Interests - ESSA